Vision Incubate Invests in Anout Inc., Developer of the 'EUREKA' Surgical AI Support System
In May 2026, Vision Incubate invested in Anout Inc., a MedTech startup that develops the 'EUREKA' surgical AI system designed to improve patient safety by analyzing intraoperative data in real-time. Vision Incubate, a venture capital fund originating from Kanazawa University, recognized Anout's innovative AI technology and aims to accelerate its commercialization through research collaborations and network leverage.
📋 Article Processing Timeline
- 📰 Published: May 21, 2026 at 14:00
- 🔍 Collected: May 21, 2026 at 05:31
- 🤖 AI Analyzed: May 21, 2026 at 05:32 (0 min after Collected)
Vision Incubate Co., Ltd. (Headquarters: Kanazawa City, Ishikawa Prefecture; Representative Director: Kunio Matsumoto; hereinafter referred to as 'the Company') is pleased to announce that it has executed an investment in Anout Inc. (Chiyoda-ku, Tokyo; Representative Director: Nao Kobayashi; hereinafter referred to as 'Anout') as of May 2026.
Anout is a MedTech startup with a mission to 'deliver greater safety and peace of mind to all patients requiring surgery.' They have developed the surgical AI system 'EUREKA,' which utilizes advanced image recognition technology to analyze complex intraoperative data in real-time, supporting surgeons' situational awareness. By merging surgical expertise with the latest digital technology, Anout aims to realize safer operating rooms.
The Company is committed to the social implementation of exceptional research achievements created by academia. We decided to invest after highly evaluating Anout's original AI technology and their global potential to lead a paradigm shift in surgical care. Moving forward, we will continue to contribute to building next-generation medical infrastructure and a sustainable society by supporting innovative medical technologies.
Nao Kobayashi, Representative Director of Anout Inc.
'We are deeply honored to have received this investment from Vision Incubate, which was established by Kanazawa University, an institution with profound knowledge and extensive achievements in surgical care. Anout is dedicated to the development and dissemination of AI medical devices that bring innovative changes to surgery, working in collaboration with medical institutions both in Japan and overseas. Through this investment, our collaborative research with Kanazawa University will be further deepened, and I am confident that by combining our efforts with the expertise and network of Vision Incubate, we will be able to accelerate the realization and widespread adoption of innovation.'
Mizuho Takeda, Director of Vision Incubate
'I am very pleased to have had the opportunity to invest in Anout. I am convinced that the 'Real-time Surgical Visual Support Technology using AI' developed by Anout is a technology that will fundamentally transform the safety of surgery by fusing unique data selection based on Representative Director Dr. Kobayashi's experience with advanced medical knowledge. Furthermore, their product will quickly improve the skill levels in surgery, which have previously depended on on-site experience, and realize high-quality standardization. Together with them, we will strive to build next-generation medical infrastructure and provide our full support.'
Anout is a MedTech startup with a mission to 'deliver greater safety and peace of mind to all patients requiring surgery.' They have developed the surgical AI system 'EUREKA,' which utilizes advanced image recognition technology to analyze complex intraoperative data in real-time, supporting surgeons' situational awareness. By merging surgical expertise with the latest digital technology, Anout aims to realize safer operating rooms.
The Company is committed to the social implementation of exceptional research achievements created by academia. We decided to invest after highly evaluating Anout's original AI technology and their global potential to lead a paradigm shift in surgical care. Moving forward, we will continue to contribute to building next-generation medical infrastructure and a sustainable society by supporting innovative medical technologies.
Nao Kobayashi, Representative Director of Anout Inc.
'We are deeply honored to have received this investment from Vision Incubate, which was established by Kanazawa University, an institution with profound knowledge and extensive achievements in surgical care. Anout is dedicated to the development and dissemination of AI medical devices that bring innovative changes to surgery, working in collaboration with medical institutions both in Japan and overseas. Through this investment, our collaborative research with Kanazawa University will be further deepened, and I am confident that by combining our efforts with the expertise and network of Vision Incubate, we will be able to accelerate the realization and widespread adoption of innovation.'
Mizuho Takeda, Director of Vision Incubate
'I am very pleased to have had the opportunity to invest in Anout. I am convinced that the 'Real-time Surgical Visual Support Technology using AI' developed by Anout is a technology that will fundamentally transform the safety of surgery by fusing unique data selection based on Representative Director Dr. Kobayashi's experience with advanced medical knowledge. Furthermore, their product will quickly improve the skill levels in surgery, which have previously depended on on-site experience, and realize high-quality standardization. Together with them, we will strive to build next-generation medical infrastructure and provide our full support.'
FAQ
What is Vision Incubate?
It is a venture capital fund with Kanazawa University as its shareholder, dedicated to supporting the practical implementation of academic research.
What is Anout Inc.'s primary business?
Anout is a MedTech startup focusing on the development and deployment of the surgical AI system 'EUREKA'.
What are the benefits of this investment?
The partnership aims to deepen research collaboration with the university and leverage the VC's network to accelerate the adoption of AI medical devices.